Title: Current and emerging treatments for irritable bowel syndrome with constipation and chronic idiopathic constipation: focus on prosecretory agents.
Journal: Pharmacotherapy 20150601
Title: Metabolic and toxicological considerations for the latest drugs used to treat irritable bowel syndrome.
Journal: Expert opinion on drug metabolism & toxicology 20130401
Title: Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.
Journal: The Journal of pharmacology and experimental therapeutics 20130101
Title: Pharmacology and clinical potential of guanylyl cyclase C agonists in the treatment of ulcerative colitis.
Journal: Drug design, development and therapy 20130101
Title: Linaclotide: first global approval.
Journal: Drugs 20121112
Title: Recent advances in the management of difficult constipation.
Journal: Current gastroenterology reports 20120801
Title: Linaclotide in the management of gastrointestinal tract disorders.
Journal: Drugs of today (Barcelona, Spain : 1998) 20120301
Title: Contrasting effects of linaclotide and lubiprostone on restitution of epithelial cell barrier properties and cellular homeostasis after exposure to cell stressors.
Journal: BMC pharmacology 20120101
Title: Linaclotide: a novel approach to the treatment of irritable bowel syndrome.
Journal: The Annals of pharmacotherapy 20111201
Title: Chronic constipation: current treatment options.
Journal: Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20111001
Title: New treatment options for chronic constipation: mechanisms, efficacy and safety.
Journal: Canadian journal of gastroenterology = Journal canadien de gastroenterologie 20111001
Title: Two randomized trials of linaclotide for chronic constipation.
Journal: The New England journal of medicine 20110811
Title: Linaclotide, a synthetic guanylate cyclase C agonist, for the treatment of functional gastrointestinal disorders associated with constipation.
Journal: Expert review of gastroenterology & hepatology 20110601
Title: The pharmacokinetics, pharmacodynamics, clinical efficacy, safety and tolerability of linaclotide.
Journal: Expert opinion on drug metabolism & toxicology 20110501
Title: Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis.
Journal: Gut 20110201
Title: IBS in 2010: advances in pathophysiology, diagnosis and treatment.
Journal: Nature reviews. Gastroenterology & hepatology 20110201
Title: Optimized Fmoc solid-phase synthesis of the cysteine-rich peptide linaclotide.
Journal: Biopolymers 20110101
Title: Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit.
Journal: European journal of pharmacology 20101215
Title: Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation.
Journal: Gastroenterology 20101201
Title: Emerging pharmacologic therapies for irritable bowel syndrome.
Journal: Current gastroenterology reports 20101001
Title: Molecule of the month. Linaclotide acetate.
Journal: Drug news & perspectives 20101001
Title: Bacterial heat-stable enterotoxins: translation of pathogenic peptides into novel targeted diagnostics and therapeutics.
Journal: Toxins 20100801
Title: Constipation: Linaclotide--a stimulating new drug for chronic constipation.
Journal: Nature reviews. Gastroenterology & hepatology 20100701
Title: [New drugs for the treatment of constipation].
Journal: Medizinische Klinik (Munich, Germany : 1983) 20100701
Title: Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract.
Journal: Life sciences 20100508
Title: Guanylate cyclase C-mediated antinociceptive effects of linaclotide in rodent models of visceral pain.
Journal: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20100301
Title: Efficacy of linaclotide for patients with chronic constipation.
Journal: Gastroenterology 20100301
Title: Taking a lesson from microbial diarrheagenesis in the management of chronic constipation.
Journal: Gastroenterology 20100301
Title: Linaclotide - a secretagogue and antihyperalgesic agent - what next?
Journal: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20100301
Title: The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation.
Journal: Advances in therapy 20090501
Title: Pilot study on the effect of linaclotide in patients with chronic constipation.
Journal: The American journal of gastroenterology 20090101
Title: Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
Journal: Gastroenterology 20070901
Title: Linaclotide, a new direction in the treatment of irritable bowel syndrome and chronic constipation.
Journal: Current opinion in molecular therapeutics 20070801
Title: Bryant AP, et al. Linaclotide is a potent and selective guanylate cyclase C agonist that elicits pharmacological effects locally in the gastrointestinal tract. Life Sci. 2010 May 8;86(19-20):760-5.
Title: Love BL, et al. Linaclotide: a novel agent for chronic constipation and irritable bowel syndrome. Am J Health Syst Pharm. 2014 Jul 1;71(13):1081-91.
